Oliver Schnell

759 total citations
18 papers, 546 citations indexed

About

Oliver Schnell is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Oliver Schnell has authored 18 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Oliver Schnell's work include Diabetes Management and Research (12 papers), Diabetes Treatment and Management (12 papers) and Metabolism, Diabetes, and Cancer (6 papers). Oliver Schnell is often cited by papers focused on Diabetes Management and Research (12 papers), Diabetes Treatment and Management (12 papers) and Metabolism, Diabetes, and Cancer (6 papers). Oliver Schnell collaborates with scholars based in Germany, Italy and United States. Oliver Schnell's co-authors include Antonio Ceriello, Eberhard Standl, Christian Weber, Bruno Vergès, Kari Harno, Péter Kempler, W Grzeszczak, Peter Diem, İlhan Satman and Tadej Battelino and has published in prestigious journals such as Diabetes Care, BMC Medicine and Diabetes Obesity and Metabolism.

In The Last Decade

Oliver Schnell

18 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver Schnell Germany 11 403 106 101 75 55 18 546
K. Jameson United Kingdom 9 463 1.1× 93 0.9× 147 1.5× 88 1.2× 43 0.8× 14 613
Hernán García Chile 15 270 0.7× 137 1.3× 145 1.4× 69 0.9× 106 1.9× 42 578
Cristóbal Morales Spain 13 360 0.9× 151 1.4× 113 1.1× 73 1.0× 69 1.3× 51 536
Margaret Tiktin United States 6 336 0.8× 86 0.8× 64 0.6× 37 0.5× 80 1.5× 7 480
Emil Martinka Slovakia 10 345 0.9× 98 0.9× 111 1.1× 85 1.1× 44 0.8× 35 545
Bethany Warren United States 7 369 0.9× 89 0.8× 67 0.7× 62 0.8× 66 1.2× 13 465
Gregg D. Simonson United States 12 204 0.5× 151 1.4× 115 1.1× 94 1.3× 37 0.7× 32 556
Miho Senda Japan 8 206 0.5× 67 0.6× 83 0.8× 49 0.7× 61 1.1× 17 472
L. Raymond Reynolds United States 11 235 0.6× 103 1.0× 84 0.8× 42 0.6× 32 0.6× 27 412
Muhammad Mujammami Saudi Arabia 12 223 0.6× 129 1.2× 101 1.0× 169 2.3× 42 0.8× 40 546

Countries citing papers authored by Oliver Schnell

Since Specialization
Citations

This map shows the geographic impact of Oliver Schnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Schnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Schnell more than expected).

Fields of papers citing papers by Oliver Schnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Schnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Schnell. The network helps show where Oliver Schnell may publish in the future.

Co-authorship network of co-authors of Oliver Schnell

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Schnell. A scholar is included among the top collaborators of Oliver Schnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Schnell. Oliver Schnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Först, Thomas, Christophe De Block, Stefano Del Prato, et al.. (2025). Novel pharmacotherapies for weight loss: Understanding the role of incretins to enable weight loss and improved health outcomes. Diabetes Obesity and Metabolism. 27(S2). 48–65. 2 indexed citations
2.
Först, Thomas, Christophe De Block, Stefano Del Prato, et al.. (2024). The role of incretin receptor agonists in the treatment of obesity. Diabetes Obesity and Metabolism. 26(10). 4178–4196. 10 indexed citations
3.
Seufert, Jochen, Stefan Gölz, Bernhard Kulzer, et al.. (2024). Kontinuierliche Glukosemessung bei Menschen mit Typ-2-Diabetes ohne intensivierte Insulintherapie: eine Standortbestimmung. Diabetologie und Stoffwechsel. 19(5). 356–368. 1 indexed citations
4.
Eichenlaub, Manuel, Şükrü Öter, Delia Waldenmaier, et al.. (2024). Characteristics of Nocturnal Hypoglycaemic Events and Their Impact on Glycaemia. Journal of Diabetes Science and Technology. 18(5). 1035–1043. 3 indexed citations
5.
Blüher, Matthias, Antonio Ceriello, Melanie J. Davies, et al.. (2022). Managing weight and glycaemic targets in people with type 2 diabetes—How far have we come?. Endocrinology Diabetes & Metabolism. 5(3). e00330–e00330. 17 indexed citations
6.
Först, Thomas, Chantal Mathieu, Francesco Giorgino, et al.. (2022). New strategies to improve clinical outcomes for diabetic kidney disease. BMC Medicine. 20(1). 337–337. 61 indexed citations
7.
Ceriello, Antonio, Eberhard Standl, Doina Catrinoiu, et al.. (2020). Issues for the management of people with diabetes and COVID-19 in ICU. Cardiovascular Diabetology. 19(1). 114–114. 28 indexed citations
8.
Schnell, Oliver, et al.. (2019). Patient-centred care in type 2 diabetes mellitus – Key aspects of PDM-ProValue are reflected in the 2018 ADA/EASD consensus report. Diabetes Research and Clinical Practice. 158. 107897–107897. 7 indexed citations
9.
Schnell, Oliver, Eberhard Standl, Doina Catrinoiu, et al.. (2016). Report from the 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group. Cardiovascular Diabetology. 15(1). 30–30. 46 indexed citations
10.
Schnell, Oliver, Hasan Alawi, Tadej Battelino, et al.. (2013). Self-Monitoring of Blood Glucose in Type 2 Diabetes: Recent Studies. Journal of Diabetes Science and Technology. 7(2). 478–488. 54 indexed citations
11.
Ceriello, Antonio, László Barkai, Jens Sandahl Christiansen, et al.. (2012). Diabetes as a case study of chronic disease management with a personalized approach: The role of a structured feedback loop. Diabetes Research and Clinical Practice. 98(1). 5–10. 48 indexed citations
12.
Schnell, Oliver, Hasan Alawi, Tadej Battelino, et al.. (2012). The Role of Self-Monitoring of Blood Glucose in Glucagon-like Peptide-1-Based Treatment Approaches: A European Expert Recommendation. Journal of Diabetes Science and Technology. 6(3). 665–673. 10 indexed citations
13.
Schnell, Oliver, Hasan Alawi, Tadej Battelino, et al.. (2011). Addressing Schemes of Self-Monitoring of Blood Glucose in Type 2 Diabetes: A European Perspective and Expert Recommendation. Diabetes Technology & Therapeutics. 13(9). 959–965. 40 indexed citations
14.
Standl, Eberhard, Oliver Schnell, & Antonio Ceriello. (2011). Postprandial Hyperglycemia and Glycemic Variability. Diabetes Care. 34(Supplement_2). S120–S127. 143 indexed citations
15.
Schnell, Oliver, Tadej Battelino, Antonio Ceriello, et al.. (2009). Consensus statement on self-monitoring of blood glucose in diabetes: A European perspective. 18(4). 285–289. 17 indexed citations
16.
Weber, Christian & Oliver Schnell. (2009). The Assessment of Glycemic Variability and Its Impact on Diabetes-Related Complications: An Overview. Diabetes Technology & Therapeutics. 11(10). 623–633. 53 indexed citations
17.
Standl, Eberhard & Oliver Schnell. (2008). Insulin as a First-Line Therapy in Type 2 Diabetes. Diabetes Care. 31(Supplement_2). S136–S139. 5 indexed citations
18.
Schnell, Oliver. (2002). Szintigraphische Charakterisierung von Blutflussregulation und sympathischer Funktion des Herzens bei Diabetikern. DMW - Deutsche Medizinische Wochenschrift. 127(18). 965–970. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Jameson Breakdown of academic impact, for papers by Hernán García Breakdown of academic impact, for papers by Cristóbal Morales Breakdown of academic impact, for papers by Margaret Tiktin Breakdown of academic impact, for papers by Emil Martinka Breakdown of academic impact, for papers by Bethany Warren Breakdown of academic impact, for papers by Gregg D. Simonson Breakdown of academic impact, for papers by Miho Senda Breakdown of academic impact, for papers by L. Raymond Reynolds Breakdown of academic impact, for papers by Muhammad Mujammami
Rankless by CCL
2026